US$ 21.65
dual agonist tirzepatide Main physiological actions of the GIP and GLP-1 Pricing is for a 28 Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
Retatrutide is not approved by Health Canada, the FDA, or any regulatory authority for any indication as of December 2025

If your side effects are hard to cope with, or youre worried about them, speak to your prescriber

Glucose uptake assay Glucose uptake in 3T3-L1 adipocytes and L6-GLUT4myc myotubes was measured using a glucose uptake cell-based assay kit (Cayman, Ann Arbor, MI, USA), according to the manufacturers protocol

Eles foram inicialmente introduzidos na medicina para o tratamento do diabetes em 2005 e para a obesidade em 2014
It also plays a role in tissue repair and metabolic regulation
